Cargando…

Association between programmed cell death ligand 1 expression and thyroid cancer: A meta-analysis

BACKGROUND: Programmed cell death ligand 1 (PD-L1), which is highly expressed in a variety of malignant tumors, is closely related to clinicopathological features and prognosis. However, there are few studies on the potential effects of PD-L1 on thyroid carcinoma, the incidence of which has shown an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Baoyu, Deng, Pengyi, Dai, Wenli, Wang, Peng, Dong, Zhizhi, Yang, Chaojun, Tian, Jinling, Hu, Tao, Yan, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036129/ https://www.ncbi.nlm.nih.gov/pubmed/33832105 http://dx.doi.org/10.1097/MD.0000000000025315

Ejemplares similares

The relationship between pneumonitis and programmed cell death-1/programmed cell death ligand 1 inhibitors among cancer patients: A systematic review and meta-analysis
por: Xu, Dongmei, et al.
Publicado: (2020)

The incidence of pseudoprogressive disease associated with programmed cell death 1/programmed cell death ligand 1 inhibitors: A meta-analysis
por: Zhang, Jingyi, et al.
Publicado: (2021)

The incidence risk of programmed cell death-1/programmed cell death ligand 1 inhibitor-related alopecia for cancer patients: A systematic review and meta-analysis
por: Li, Mingkai, et al.
Publicado: (2020)

Adverse cardiac events in the treatment of non-small cell lung cancer with programmed death-1and programmed death-ligand 1 inhibitors: A protocol for systematic review and meta-analysis
por: Li, Honglin, et al.
Publicado: (2020)

Prognostic significance of circulating soluble programmed death ligand-1 in patients with solid tumors: A meta-analysis
por: Wei, Wei, et al.
Publicado: (2018)

The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma: A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines
por: Guan, Xiuwen, et al.
Publicado: (2016)

The prediction potential of neutrophil-to-lymphocyte ratio for the therapeutic outcomes of programmed death receptor-1/programmed death ligand 1 inhibitors in non-small cell lung cancer patients: A meta-analysis
por: Huang, Ying, et al.
Publicado: (2020)

Plasma levels of soluble programmed death ligand-1 may be associated with overall survival in nonsmall cell lung cancer patients receiving thoracic radiotherapy
por: Zhao, Jing, et al.
Publicado: (2017)

Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer: A Meta-Analysis
por: Zhang, Yaxiong, et al.
Publicado: (2015)

Plasma levels of soluble programmed death ligand 1 (sPD-L1) in WHO II/III nasopharyngeal carcinoma (NPC): A preliminary study
por: Yang, Jia, et al.
Publicado: (2019)

Detection of programmed death ligand 1 protein and CD8(+) lymphocyte infiltration in plurihormonal pituitary adenomas: A case report and review of the literatures
por: Wang, Pengfei, et al.
Publicado: (2017)

The relationship between iodine intake and the risk of thyroid cancer: A meta-analysis
por: Cao, Ling-Zhi, et al.
Publicado: (2017)

Diagnostic value of cell-free DNA in thyroid cancer: A systematic review and meta-analysis
por: Hou, Fei, et al.
Publicado: (2023)

Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma
por: Bylicki, Olivier, et al.
Publicado: (2020)

Anaplastic thyroid carcinoma combined with sclerosing mucoepidermoid carcinoma with eosinophilia: A case report
por: Mao, Ruiqi, et al.
Publicado: (2020)

Circulating tumor cells counts are associated with CD8+ T cell levels in programmed death-ligand 1-negative non-small cell lung cancer patients after radiotherapy: A retrospective study
por: Liu, Qingyun, et al.
Publicado: (2021)

Thyroid metastasis from chondrosarcoma
por: Wu, Zhi-Hong, et al.
Publicado: (2019)

Coexistence of Papillary Thyroid Carcinoma With Thyroid MALT Lymphoma in a Patient With Hashimoto's Thyroiditis: A Clinical Case Report
por: Shen, Guohua, et al.
Publicado: (2015)

Prognostic value of semi-quantitative parameters of (18)F-FDG PET/CT in newly diagnosed multiple myeloma patients
por: Wan, Baoyu, et al.
Publicado: (2022)

A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma
por: Wang, Tao, et al.
Publicado: (2021)

Prognostic role of the lymphocyte-to-monocyte ratio in colorectal cancer: An up-to-date meta-analysis
por: Wu, Qingbin, et al.
Publicado: (2017)

Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies
por: Li, Hongtao, et al.
Publicado: (2017)

The Efficacy of Erlotinib Versus Conventional Chemotherapy for Advanced Nonsmall-Cell Lung Cancer: A PRISMA-Compliant Systematic Review With Meta-Regression and Meta-Analysis
por: Ma, Hu, et al.
Publicado: (2016)

Prognostic significance of X-linked inhibitor of apoptosis protein in patients with gastrointestinal tract cancers: A meta-analysis
por: Ieong, Chengcheng, et al.
Publicado: (2020)

Ultrasonographic characteristics of thyroid metastasis from clear cell renal cell carcinoma: A case report
por: Tian, Peng, et al.
Publicado: (2020)

Comprehensive analysis of diverse programmed cell death patterns in the prognosis, tumor microenvironment and drug sensitivity in hepatocellular carcinoma
por: Yu, Youlin, et al.
Publicado: (2023)

Value of contrast-enhanced ultrasound in differential diagnosis of solid lesions of pancreas (SLP): A systematic review and a meta-analysis
por: Ran, Li, et al.
Publicado: (2017)

Replication and Meta-Analysis of Common Gene Mutations in TTF1 and TTF2 with Papillary Thyroid Cancer
por: Gao, Yan, et al.
Publicado: (2015)

Survival of patients with advanced pancreatic cancer after iodine(125) seeds implantation brachytherapy: A meta-analysis
por: Han, Quanli, et al.
Publicado: (2017)

The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study
por: Zhu, Feng, et al.
Publicado: (2016)

Treatment of medullary thyroid carcinoma with apatinib: A case report and literature review
por: Cai, Sina, et al.
Publicado: (2017)

Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review
por: Ding, Ran, et al.
Publicado: (2023)

Temozolomide plus whole brain radiotherapy for the treatment of non-small-cell lung cancer patients with brain metastases: A protocol of an updated systematic review and meta-analysis
por: Duan, Hua, et al.
Publicado: (2020)

Diagnostic value of routine ultrasonography combined with ultrasound elastography for papillary thyroid microcarcinoma: A protocol for systematic review and meta-analysis
por: Du, Yanfei, et al.
Publicado: (2021)

Real-world treatment efficacy of anti-programmed death-1 combined with anti-angiogenesis therapy in non-small cell lung cancer patients
por: Qiu, Lupeng, et al.
Publicado: (2020)

The Adverse Events of Oxycodone in Cancer-Related Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ma, Hu, et al.
Publicado: (2016)

Hepatitis B virus infection does not affect the clinical outcome of anti-programmed death receptor-1 therapy in advanced solid malignancies: Real-world evidence from a retrospective study using propensity score matching
por: Zhong, Liting, et al.
Publicado: (2021)

Effect of Quxie capsule in patients with colorectal cancer: A systematic review and meta-analysis
por: Zhang, Suqin, et al.
Publicado: (2021)

Synchronous double primary lymphoma and thyroid cancer: A single-institution retrospective study
por: Li, Qiuhui, et al.
Publicado: (2021)

Evaluation of voice function after BABA robotic thyroid lobectomy: A comparative analysis with endoscopic thyroid lobectomy
por: Liu, Peigen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d3lv8r6rme7644f4bevs9f3cnl